BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 19180561)

  • 1. Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis.
    Ferrari G; Cook BD; Terushkin V; Pintucci G; Mignatti P
    J Cell Physiol; 2009 May; 219(2):449-58. PubMed ID: 19180561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis.
    Ferrari G; Pintucci G; Seghezzi G; Hyman K; Galloway AC; Mignatti P
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17260-5. PubMed ID: 17088559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of transforming growth factor-β1 and vascular endothelial growth factor in Fabry disease nephropathy.
    Lee MH; Choi EN; Jeon YJ; Jung SC
    Int J Mol Med; 2012 Dec; 30(6):1275-80. PubMed ID: 23007467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38β to proapoptotic p38α.
    Ferrari G; Terushkin V; Wolff MJ; Zhang X; Valacca C; Poggio P; Pintucci G; Mignatti P
    Mol Cancer Res; 2012 May; 10(5):605-14. PubMed ID: 22522454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
    Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
    Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of endothelial cell associated VEGFR2 during TGF-β modulated angiogenesis in vitro.
    Jarad M; Kuczynski EA; Morrison J; Viloria-Petit AM; Coomber BL
    BMC Cell Biol; 2017 Jan; 18(1):10. PubMed ID: 28114883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis.
    Jeon SH; Chae BC; Kim HA; Seo GY; Seo DW; Chun GT; Kim NS; Yie SW; Byeon WH; Eom SH; Ha KS; Kim YM; Kim PH
    J Leukoc Biol; 2007 Feb; 81(2):557-66. PubMed ID: 17053163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta1 protects against pulmonary artery endothelial cell apoptosis via ALK5.
    Lu Q
    Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L123-33. PubMed ID: 18456797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta1 induces rearrangement of FLK-1-VE-cadherin-beta-catenin complex at the adherens junction through VEGF-mediated signaling.
    Cook BD; Ferrari G; Pintucci G; Mignatti P
    J Cell Biochem; 2008 Dec; 105(6):1367-73. PubMed ID: 18980215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
    Stepanova V; Jayaraman PS; Zaitsev SV; Lebedeva T; Bdeir K; Kershaw R; Holman KR; Parfyonova YV; Semina EV; Beloglazova IB; Tkachuk VA; Cines DB
    J Biol Chem; 2016 Jul; 291(29):15029-45. PubMed ID: 27151212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M; Muragaki Y; Ooshima A
    Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma.
    Maharaj AS; Walshe TE; Saint-Geniez M; Venkatesha S; Maldonado AE; Himes NC; Matharu KS; Karumanchi SA; D'Amore PA
    J Exp Med; 2008 Feb; 205(2):491-501. PubMed ID: 18268040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
    Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
    Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
    Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ
    Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inhibition of tumor angiogenesis by beta-hydroxyisovalerylshikonin.
    Komi Y; Suzuki Y; Shimamura M; Kajimoto S; Nakajo S; Masuda M; Shibuya M; Itabe H; Shimokado K; Oettgen P; Nakaya K; Kojima S
    Cancer Sci; 2009 Feb; 100(2):269-77. PubMed ID: 19200258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of placental growth factor upregulated via TGF-β1-ALK1-Smad1/5 signaling in prohaptoglobin-induced angiogenesis.
    Oh MK; Kim IS
    PLoS One; 2019; 14(4):e0216289. PubMed ID: 31034502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal carcinoma cell production of transforming growth factor beta decreases expression of endothelial cell vascular endothelial growth factor receptor 2.
    Kuczynski EA; Viloria-Petit AM; Coomber BL
    Cancer; 2011 Dec; 117(24):5601-11. PubMed ID: 21692070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Phosphotyrosine Phosphatase 1B (PTP1B) in Calpain-dependent Feedback Regulation of Vascular Endothelial Growth Factor Receptor (VEGFR2) in Endothelial Cells: IMPLICATIONS IN VEGF-DEPENDENT ANGIOGENESIS AND DIABETIC WOUND HEALING.
    Zhang Y; Li Q; Youn JY; Cai H
    J Biol Chem; 2017 Jan; 292(2):407-416. PubMed ID: 27872190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
    Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
    Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.